Press release
Oligonucleotide Therapeutics Market Trends Estimates High Demand By 2016 – 2024
Oligonucleotide therapeutics are different from conventional medicine as they can inhibit the expression of certain genes. This has given rise to innovative new oligonucleotides that can target specific genes and treat chronic diseases. The development of oligonucleotide therapeutics is done through chemically modified artificial nucleic acids. The artificial oligonucleotides are being developed which has improved in vivo stability and enhanced affinity to target mRNA.
Oligonucleotide Therapeutics Market: Dynamics
The demand for oligonucleotides is expected to upsurge as there are very few approved molecules. This has offered oligonucleotide market players a wide scope to discover new molecular entities. Moreover, the technology upgrades of chemically synthesized oligonucleotides have led to the development of more stable and extended half-life molecules. There are around 135 oligonucleotide therapeutics currently in different stages of drug development, which may further add to the limited three approved drugs currently available in the oligonucleotide therapeutics market.
Oligonucleotide Therapeutics Market: Segmentation
On the basis of application, the oligonucleotide therapeutics market can be segmented as:
Infectious diseases
Oncology
Neurodegenerative disorders
Cardiovascular diseases
Kidney diseases
Others
The area of treatment with oligonucleotides is wide and offers promising results. Oligonucleotides have a distinguishing feature as compared to small molecule and protein therapeutics in that it can directly affect the protein targets. Specific RNA interference at the cellular level and targeting malfunctioning gene to suppress, manipulate or silence can all be done via oligonucleotides therapeutics.
On the basis of type, the oligonucleotide therapeutics market can be segmented as:
Antisense
Ribozymes
Aptamers
miRNA
CpG/Immunostimulatory
RNAi
The number of oligonucleotides in the clinical pipeline is small compared to other therapeutic classes, but still, the clinical movement of these molecules is increasing. From 2012 to 2015, the biggest increase in oligonucleotides clinical phase was from Phase 1 to Phase 2. By mid-2015, the number of oligonucleotides in Phase 2 almost doubled than that in Phase 1, indicating that the pipeline is maturing.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/12787
Oligonucleotide Therapeutics Market: Region-wise Outlook
The presence of the main market leaders, market consolidation and commercialization of new molecules are all contributing towards the dominating position of North America in the oligonucleotides therapeutic market. Miragen Therapeutics, Inc. agreed to merge with Signal Genetics, Inc for an initial investment of USD 40 million. Through this merger both the companies expect to develop micro RNA-targeted oligonucleotide clinical products. New molecule application is also another strategy the market players are using to mark their presence in the oligonucleotide therapeutic market. Biogen recently received FDA approval for a new drug application for nusinersen. If approved, the antisense oligonucleotides molecule would be the first of its kind to be used for treating spinal muscular atrophy.
Asia-Pacific is the fastest growing region as several oligonucleotide therapeutics manufacturers are looking forward to establishing manufacturing facilities in this region. Moreover, research undertaking and funding in the synthesis of oligonucleotides are expected to add on to the increasing demand. Recently, Daiichi Sankyo Co., Ltd. announced its intention to open up a new company named Orphan Disease Treatment Institute Co., Ltd. to treat Duchenne muscular dystrophy through its active ingredient ENA oligonucleotide. The company is a collaboration between Daiichi, Mitsubishi UFJ Capital Co., Ltd. and Innovation Network Corporation of Japan and looks forward to entering the oligonucleotide therapeutics market.
Oligonucleotide Therapeutics Market: Market Players
One of the major trends driving the oligonucleotides therapeutic market is the increasing licensing and collaboration activities. Moreover, the demand for advanced technologies in oligonucleotide therapeutics such as gene silencing through RNAi is gaining importance due to its high efficiency, thereby propelling the oligonucleotide therapeutics market.
Some of the key contributors to the oligonucleotide therapeutics market are PCI Biotech, SomaGenics, ContraVir, Alnylam, Regulus Therapeutics, Ionis Pharmaceuticals, Gilead, Santaris, InteRNA, miRage, Biogen, Merck and Pfizer, among others.
To view complete report @ http://www.persistencemarketresearch.com/market-research/oligonucleotide-therapeutics-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oligonucleotide Therapeutics Market Trends Estimates High Demand By 2016 – 2024 here
News-ID: 642455 • Views: …
More Releases from Persistence Market Research
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview:
The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period.
Market Size and Growth:
The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and…
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction
Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities.
Get Access To…
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview:
The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033.
The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an…
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products.
To obtain the latest market…
More Releases for Oligonucleotide
Oligonucleotide Synthesis Market Size and Share 2022-2027
According to IMARC Group's latest report, titled "Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global oligonucleotide synthesis market reached a value of US$ 2.4 Billion in 2021. Oligonucleotide synthesis is the chemical synthesis of little fragments of nucleic acids that are produced through enzymatic chemistry and genetic engineering. It is used in laboratories for diagnostics, academic, industrial, and therapeutic applications. Oligonucleotide synthesis helps in building…
Oligonucleotide Synthesis Market Growing with Rising Cancer Burden
The most-prominent factors leading to the growth of the oligonucleotide synthesis market are the technological advancements in the field, increasing government support, rising number of research studies related to synthetic biology, and surging incidence of infections and cancer. As a result, the worth of the sales of synthesized oligonucleotides will increase from $1.5 billion in 2017 to $2.8 billion by 2023, at a 10.8% CAGR during the forecast period (2018–2023).…
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis…
Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment …
Research Report on "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025".
Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis market revenue growth and the factors likely to impact this growth during the period of forecast. The report describes the scenario of…
Global Oligonucleotide Market Research Report Forecast 2017-2021
The report, titled Global Oligonucleotide Market 2017 is a methodical research study based on the Oligonucleotide market, analyzing the competitive framework of the industry in the world. Using efficient analytical tools such as SWOT analysis and Porter’s five forces analysis, the report provides a comprehensive assessment of the Oligonucleotide market.
The report estimates the market size in terms of volume (kilo tons) and revenue (US$) produced, whereas, the key segments and…
Oligonucleotide Synthesis Market 2017 Development Trends
This report studies the global Oligonucleotide Synthesis market, analyzes and researches the Oligonucleotide Synthesis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Agilent Technologies
Biosearch Technologies
Eurofins Genomics
Eurogentec
Integrated DNA Technologies
Merck KGAA
Thermo Fisher Scientific
GeneDesign
Bio-Synthesis - CRO/CMO Life Sciences Company
Bioautomation
GE Healthcare
LGC Biosearch Technologies
NITTO Denko Avecia
For more information about this report at http://www.reportsweb.com/global-oligonucleotide-synthesis-market-size-status-and-forecast-2022
Market segment by Regions/Countries, this report…
